You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nab-paclitaxel

Showing 26 - 50 of 3,408
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Dec 5, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

Active, not recruiting
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Nov 29, 2022

Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

Recruiting
  • Triple Negative Breast Cancer Metastatic
  • Milano, Italy
  • +1 more
Jan 16, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus

Not yet recruiting
  • Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
  • NAB-Paclitaxel plus Cisplatin
  • Cisplatin plus Epirubicin plus Cyclophosphamide
  • Shanghai, Shanghai, China
    Yian Zhang
Apr 17, 2023

Atezolizumab With Nab-paclitaxel for Triple-negative Stage IV

Completed
  • Breast Cancer Metastatic
  • Atezolizumab in combination with nab-paclitaxel
  • Roma, RM, Italy
    Policlinico A. Gemelli - IRCCS
Nov 2, 2022

KRAS Activating Mutation, Metastatic Cancer, Pancreas Cancer Trial in Saint Louis (avutometinib (VS-6766) and defactinib in

Recruiting
  • KRAS Activating Mutation
  • +4 more
  • avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Melanoma Trial in Rochester (Biopsy, Biospecimen

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

Soft Tissue Sarcoma Trial in Switzerland (Nab-Paclitaxel, gemcitabine)

Terminated
  • Soft Tissue Sarcoma
  • Basel, Switzerland
  • +7 more
Sep 27, 2022

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in

Not yet recruiting
  • Locally Advanced Cholangiocarcinoma
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      CHA Bundang Medical Center
    Jan 24, 2023

    Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)

    Recruiting
    • Locally Advanced Pancreatic Cancer
    • Washington, District of Columbia
    • +1 more
    Oct 10, 2022

    Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)

    Not yet recruiting
    • Pancreas Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 15, 2022

    Pancreatic Adenocarcinoma, Metastatic Trial in Spain, United States (Nab-paclitaxel, Gemcitabine, VCN-01)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Metastatic
    • Nab-paclitaxel
    • +2 more
    • New York, New York
    • +7 more
    Jan 3, 2023

    Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

    Active, not recruiting
    Has Results
    • Pancreatic Ductal Adenocarcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Dec 8, 2022

    First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,

    Not yet recruiting
    • First-line Treatment of Advanced Pancreatic Cancer
    • HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
    • nab-paclitaxel; gemcitabine
    • (no location specified)
    Feb 28, 2023

    Breast Cancer Trial (Intuzumab, pyrrolidone, nab-paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • Intuzumab, pyrrolidone, nab-paclitaxel
    • (no location specified)
    Jun 29, 2022

    NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer Metastatic
    • (no location specified)
    Jan 18, 2023

    Gastric Cancer Trial (Camrelizumab Nab-Paclitaxel S-1)

    Not yet recruiting
    • Gastric Cancer
    • Camrelizumab Nab-Paclitaxel S-1
    • (no location specified)
    Jun 20, 2022

    Adenocarcinoma of the Pancreas Trial in Italy, Spain (Valproic acid, Simvastatin 20mg, Gemcitabine 1000 mg)

    Not yet recruiting
    • Adenocarcinoma of the Pancreas
    • Valproic acid
    • +4 more
    • Milano, Italy
    • +4 more
    Apr 6, 2023

    Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic

    Active, not recruiting
    • Breast Cancer
    • New York, New York
      NYU Perlmutter Cancer Center
    Aug 5, 2022

    Breast Cancer Trial in Boston (Pembrolizumab, Nab-Paclitaxel, Biopsy)

    Active, not recruiting
    • Breast Cancer
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 22, 2022

    NSCLC Trial in Boston, New York (MPDL3280A, Carboplatin, Nab-paclitaxel)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • Boston, Massachusetts
    • +1 more
    Oct 12, 2022